Astellas Pharma Global Development

IL · United States · Reporting entity ID 100000005406

Total reported 2019–2025

$88.8M

#106 of 2,960 reporting companies — 0.1% of all reported industry payments

$3.06M in general payments across 3,010 records, plus $85.7M in research funding across 16,738 records.

How it breaks down

General payments $3,060,688

Research funding $85,693,417

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.